scispace - formally typeset
E

Eric J. Topol

Researcher at Scripps Health

Publications -  1406
Citations -  162373

Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.

Papers
More filters
Book

Cardiovascular thrombosis : thrombocardiology and thromboneurology

TL;DR: Part 1 Fundamental considerations: thrombosis and fibrinolysis, Laurence A. Harker and Kenneth G. Mann pathogenesis of thROMbosis, Lina Badimon and Meyer Michel Samama laboratory detection of the prethrombotic state, and prevention and treatment of thromboembolic disorders.
Journal ArticleDOI

Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarction

TL;DR: A fluid phase biopsy technology platform that successfully detects circulating tumor cells in the blood of cancer patients is adapted to create a high-definition circulating endothelial cell (HD-CEC) assay for the detection and characterization of CECs.
Journal ArticleDOI

Experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials

TL;DR: Reinfarction occurs infrequently after fibrinolysis but confers increased risk of 30-day and 1-year mortality and improved treatment and prevention strategies for reinfarction deserve study.
Journal ArticleDOI

A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I trial)

TL;DR: Directional coronary atherectomy was associated with less angiographic residual stenosis, but with a higher rate of side-branch closure and non-Q-wave myocardial infarction.
Journal ArticleDOI

Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)

TL;DR: In patients with acute coronary syndromes who received a coronary stent as part of routine care during 2 trials of aspirin versus sibrafiban for secondary prevention, stent thrombosis occurred more often than in previous patients who underwent elective percutaneous coronary intervention.